"The license includes certain preference conditions that cap the number of similar phenotypic deals Phylogica may enter into during an 18 month option period. "
What i'd really like to know is a number associated with how many deals this has been capped at ? or is that it it's capped as Phoremost being the only phenotypic deal for 18 months ? It's just a little vague leaving out a number when you would think that would be standard in the release. Not that phenotypic deals are the only deals that are out there or anything but just a bit of clarity would be good especially if Phoremost start hitting some big targets you would then assume other company's interest would be firing up.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)